Table 1.
Baseline sample characteristics for study population, complete cases and comparing trial to non-trial participants restricted to complete cases.
Table 2.
Details of Clinical Trials included in this study: Number of Patients, Study Design and Study Title.
Figure 1.
Antiretroviral treatment by trial participation.
Table 3.
Risk Ratios for virologic suppression by trial participation within strata of HAART period.
Figure 2.
Sensitivity Analyis: Risk Ratios for viral suppression following different adjustment schema for missing data.